Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics

Epilepsia

Volumn 56, Issue 8, 2015, Pages 1185-1197

  Wilmshurst, Jo M ^a   Gaillard, William D ^b   Vinayan, Kollencheri Puthenveettil ^c   Tsuchida, Tammy N ^d   Plouin, Perrine ^e   Van Bogaert, Patrick ^f   Carrizosa, Jaime ^g   Elia, Maurizio ^h   Craiu, Dana ^i,j   Jovic, Nebojsa J ^k   Nordli, Doug ^l   Hirtz, Deborah ^m   Wong, Virginia ^n,o   Glauser, Tracy ^p   Mizrahi, Eli M ^q   Cross, J Helen ^r  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e INSERM   (France)

^f ERASME HOSPITAL   (Belgium)

^g UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^h OASI RESEARCH INSTITUTE IRCCS   (Italy)

ⁱ CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^j Al Obregia Clinical Hospital   (Romania)

^k UNIVERSITY OF BELGRADE   (Serbia)

^l CHILDREN'S MEMORIAL HOSPITAL   (United States)

^m NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

ⁿ UNIVERSITY OF HONG KONG   (Hong Kong)

^o QUEEN MARY HOSPITAL   (Hong Kong)

^p CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^q BAYLOR COLLEGE OF MEDICINE   (United States)

^r GREAT ORMOND STREET HOSPITAL   (United Kingdom)

more..

Author keywords

Guidelines; Infants; Optimal care; Recommendations; Seizures; Standard care

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; CARBAMAZEPINE; CLOBAZAM; CORTICOTROPIN; ETIRACETAM; FELBAMATE; GABAPENTIN; GLUCOSE TRANSPORTER 1; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; PYRIDOXINE; PYRUVATE DEHYDROGENASE; STEROID; STIRIPENTOL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; ARTICLE; AUTISM; BRAIN DISEASE; CHILD DEVELOPMENT; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FEBRILE CONVULSION; FOCAL EPILEPSY; GENETIC SCREENING; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; INFANTILE SPASM; INFORMATION PROCESSING; KETOGENIC DIET; LENNOX GASTAUT SYNDROME; MEDICAL DECISION MAKING; METABOLIC ENCEPHALOPATHY; MYOCLONIC ASTATIC EPILEPSY; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OHTAHARA SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; SCREENING; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TERTIARY CARE CENTER; TERTIARY HEALTH CARE; TONIC CLONIC SEIZURE; TUBEROUS SCLEROSIS; VAGUS NERVE STIMULATION; VIDEORECORDING; ADVISORY COMMITTEE; DISEASE MANAGEMENT; NEWBORN; SEIZURES, FEBRILE; SPASMS, INFANTILE;

ADVISORY COMMITTEES; ANTICONVULSANTS; DISEASE MANAGEMENT; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; INFANT; INFANT, NEWBORN; NEUROIMAGING; PRACTICE GUIDELINES AS TOPIC; SEIZURES, FEBRILE; SPASMS, INFANTILE;

EID: 84938743062     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13057     Document Type: Article

References (75)

1. Atkins D, Best D, Briss PA, et al., Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
2. Edlund W, Gronseth G, So Y, et al. (Eds) Clinical practice guideline process manual. St Paul, MN: American Academy of Neurology; 2004.
3. Gronseth G, French J,. Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology 2008; 71: 1639-1643.
4. Subcommittee on Febrile Seizures, American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics 2011; 127: 389-394.
5. Berg AT, Shinnar S,. Complex febrile seizures. Epilepsia 1996; 37: 126-133.
6. Sapir D, Leitner Y, Harel S, et al., Unprovoked seizures after complex febrile convulsions. Brain Dev 2000; 22: 484-486.
7. Nelson KB, Ellenberg JH,. Predisposing and causative factors in childhood epilepsy. Epilepsia 1987; 28: S16-S24.
8. Wolf NI, Bast T, Surtees R,. Epilepsy in inborn errors of metabolism. Epileptic Disord 2005; 7: 67-81.
9. Arsov T, Mullen SA, Damiano JA, et al., Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 2012; 53: e204-e207.
10. Suls A, Mullen SA, Weber YG, et al., Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 2009; 66: 415-419.
11. Ottman R, Hirose S, Jain S, et al., Genetic testing in the epilepsies-report of the ILAE Genetics Commission. Epilepsia 2010; 51: 655-670.
12. Nordli DR Jr, Kuroda MM, Carroll J, et al., Experience with the ketogenic diet in infants. Pediatrics 2001; 108: 129-133.
13. Kossoff EH, Pyzik PL, McGrogan JR, et al., Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002; 109: 780-783.
14. Eun SH, Kang HC, Kim DW, et al., Ketogenic diet for treatment of infantile spasms. Brain Dev 2006; 28: 566-571.
15. Kossoff EH, Hedderick EF, Turner Z, et al., A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008; 49: 1504-1509.
16. Hong AM, Turner Z, Hamdy RF, et al., Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 2010; 51: 1403-1407.
17. Numis AL, Yellen MB, Chu-Shore CJ, et al., The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms. Epilepsy Res 2011; 96: 172-175.
18. Kang HC, Lee YJ, Lee JS, et al., Comparison of short- versus long-term ketogenic diet for intractable infantile spasms. Epilepsia 2011; 52: 781-787.
19. Hopkins IJ, Lynch BC,. Use of ketogenic diet in epilepsy in childhood. Aust Paediatr J 1970; 6: 25-29.
20. Kayyali HR, Gustafson M, Myers T, et al., Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr Neurol 2014; 50: 224-227.
21. Cross JH, Jayakar P, Nordli D, et al., Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006; 47: 952-959.
22. Blount JP, Tubbs RS, Kankirawatana P, et al., Vagus nerve stimulation in children less than 5 years old. Childs Nerv Syst 2006; 22: 1167-1169.
23. Shahwan A, Bailey C, Maxiner W, et al., Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction. Epilepsia 2009; 50: 1220-1228.
24. Cersosimo RO, Bartuluchi M, De Los Santos C, et al., Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies. Childs Nerv Syst 2011; 27: 787-792.
25. Cersosimo RO, Bartuluchi M, Fortini S, et al., Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord 2011; 13: 382-388.
26. Zamponi N, Rychlicki F, Corpaci L, et al., Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev 2008; 31: 291-297.
27. Cowan LD, Hudson LS,. The epidemiology and natural history of infantile spasms. J Child Neurol 1991; 6: 355-364.
28. Riikonen R,. Epidemiological data of West syndrome in Finland. Brain Dev 2001; 23: 539-541.
29. Shinnar S, Hesdorffer DC, Nordli DR Jr, et al., Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008; 71: 170-176.
30. Yu HJ, Lee CG, Nam SH, et al., Clinical and ictal characteristics of infantile seizures: EEG correlation via long-term video EEG monitoring. Brain Dev 2013; 35: 771-777.
31. Brunklaus A, Dorris L, Ellis R, et al., The clinical utility of an SCN1A genetic diagnosis in infantile-onset epilepsy. Dev Med Child Neurol 2013; 55: 154-161.
32. Go CY, Mackay MT, Weiss SK, et al., Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012; 78: 1974-1980.
33. Hancock EC, Osborne JP, Edwards SW,. Treatment of infantile spasms. Cochrane Database Syst Rev 2008; 4: CD001770.
34. Hancock EC, Osborne JP, Edwards SW,. Treatment of infantile spasms. Cochrane Database Syst Rev 2013; 6: CD001770.
35. Lux AL, Edwards SW, Hancock E, et al., The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004; 364: 1773-1778.
36. Lux AL, Edwards SW, Hancock E, et al., The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005; 4: 712-717.
37. Darke K, Edwards SW, Hancock E, et al., Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child 2010; 95: 382-386.
38. O'Callaghan FJ, Lux AL, Darke K, et al., The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 2011; 52: 1359-1364.
39. Johnson CP, Myers SM,; American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120: 1183-1215.
40. Kim JS, Kondratyev A, Tomita Y, et al., Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48: S19-S26.
41. Wanigasinghe J, Arambepola C, Sri Ranganathan S, et al., The efficacy of moderate-to-high dose oral prednisolone versus low-to-moderate dose intramuscular corticotropin for improvement of hypsarrhythmia in West syndrome: a randomized, single-blind, parallel clinical trial. Pediatr Neurol 2014; 51: 24-30.
42. Hussain SA, Shinnar S, Kwong G, et al., Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone. Epilepsia 2014; 55: 103-107.
43. Freitag CM, May TW, Pfafflin M, et al., Incidence of epilepsies and epileptic syndromes in children and adolescents: a population-based prospective study in Germany. Epilepsia 2001; 42: 979-985.
44. Dura-Trave T, Yoldi-Petri ME, Gallinas-Victoriano F,. Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005. J Child Neurol 2008; 23: 878-882.
45. Kurtz Z, Tookey P, Ross E,. Epilepsy in young people: 23 year follow up of the British national child development study. BMJ 1998; 316: 339-342.
46. Olafsson E, Ludvigsson P, Gudmundsson G, et al., Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005; 4: 627-634.
47. Verity CM, Ross EM, Golding J,. Epilepsy in the first 10 years of life: findings of the child health and education study. BMJ 1992; 305: 857-861.
48. Camfield CS, Camfield PR, Gordon K, et al., Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia 1996; 37: 19-23.
49. Doose H, Sitepu B,. Childhood epilepsy in a German city. Neuropediatrics 1983; 14: 220-224.
50. Granieri E, Rosati G, Tola R, et al., A descriptive study of epilepsy in the district of Copparo, Italy, 1964-1978. Epilepsia 1983; 24: 502-514.
51. Eltze CM, Chong WK, Cox T, et al., A population-based study of newly diagnosed epilepsy in infants. Epilepsia 2013; 54: 437-445.
52. Datta AN, Wirrell EC,. Prognosis of seizures occurring in the first year. Pediatr Neurol 2000; 22: 386-391.
53. Masri A, Badran E, Hamamy H, et al., Etiologies, outcomes, and risk factors for epilepsy in infants: a case-control study. Clin Neurol Neurosurg 2008; 110: 352-356.
54. Korff C, Nordli DR Jr,. Do generalized tonic-clonic seizures in infancy exist? Neurology 2005; 65: 1750-1753.
55. Matsumoto A, Watanabe K, Sugiura M, et al., Long-term prognosis of convulsive disorders in the first year of life: mental and physical development and seizure persistence. Epilepsia 1983; 24: 321-329.
56. Hsieh DT, Chang T, Tsuchida TN, et al., New-onset afebrile seizures in infants: role of neuroimaging. Neurology 2010; 74: 150-156.
57. Kwan P, Arzimanoglou A, Berg AT, et al., Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077.
58. Wirrell E, Wong-Kisiel L, Mandrekar J, et al., Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study. Epilepsia 2012; 53: 1563-1569.
59. Geerts A, Brouwer O, Stroink H, et al., Onset of intractability and its course over time: the Dutch study of epilepsy in childhood. Epilepsia 2012; 53: 741-751.
60. Dhamija R, Moseley BD, Cascino GD, et al., A population-based study of long-term outcome of epilepsy in childhood with a focal or hemispheric lesion on neuroimaging. Epilepsia 2011; 52: 1522-1526.
61. Korff CM, Nordli DR Jr,. The clinical-electrographic expression of infantile seizures. Epilepsy Res 2006; 70: S116-S131.
62. Trevathan E, Murphy CC, Yeargin-Allsopp M,. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999; 40: 748-751.
63. Zeiler SR, Kaplan PW,. Our digital world: camera phones and the diagnosis of a seizure. Lancet 2009; 373: 2136.
64. Knudsen FU,. Febrile seizures: treatment and prognosis. Epilepsia 2000; 41: 2-9.
65. Sadleir LG, Scheffer IE,. Febrile seizures. BMJ 2007; 334: 307-311.
66. Bast T, Carmant L,. Febrile and other occasional seizures. Handb Clin Neurol 2013; 111: 477-491.
67. Sfaihi L, Maaloul I, Kmiha S, et al., Febrile seizures: an epidemiological and outcome study of 482 cases. Childs Nerv Syst 2012; 28: 1779-1784.
68. Graves RC, Oehler K, Tingle LE,. Febrile seizures: risks, evaluation, and prognosis. Am Fam Physician 2012; 85: 149-153.
69. Annegers JF, Hauser WA, Shirts SB, et al., Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med 1987; 316: 493-498.
70. Vestergaard M, Pedersen CB, Sidenius P, et al., The long-term risk of epilepsy after febrile seizures in susceptible subgroups. Am J Epidemiol 2007; 165: 911-918.
71. Capovilla G, Mastrangelo M, Romeo A, et al., Recommendations for the management of "febrile seizures": Ad Hoc Task Force of LICE Guidelines Commission. Epilepsia 2009; 50: S2-S6.
72. Nagase H, Nakagawa T, Aoki K, et al., Therapeutic indicators of acute encephalopathy in patients with complex febrile seizures. Pediatr Int 2013; 55: 310-314.
73. Kim H, Byun SH, Kim JS, et al., Clinical and EEG risk factors for subsequent epilepsy in patients with complex febrile seizures. Epilepsy Res 2013; 105: 158-163.
74. Hesdorffer DC, Shinnar S, Lewis DV, et al., Risk factors for febrile status epilepticus: a case-control study. J Pediatr 2013; 163: 1147-1151.
75. Wilmshurst JM, Burman R, Gaillard WD, Cross JH,. Treatment of infants with epilepsy: Common practices around the world. Epilepsia 2015; 56: 1033-1046.